View More View Less
  • 1 Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, India
  • | 2 Advinus Therapeutics Ltd., Pune, India
  • | 3 Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, India
Restricted access

Summary

Losartan potassium (LOS), used in the treatment of hypertension, is metabolized primarily by cytochrome P450. This study investigates the effect of quercetin (QU), a CYP3A4 inducer, on the pharmacokinetics of LOS in rats. A rapid, sensitive high-performance thin-layer chromatography (HPTLC) method was developed and validated for the bioanalysis of losartan using olmesartan as internal standard (IS). The salting-out assisted liquid-liquid extraction (SALLE) employing acetonitrile and MgCl2 gave high recovery of LOS (>90%). HPTLC separation, achieved on silica gel 60 F254 plates employing toluene-ethyl acetate-acetone-formic acid (4:4:1:0.5 V/V) as the mobile phase, with densitometric analysis at 240 nm, gave good linearity (50–1200 ng mL−1) with high intra-day and inter-day precision. LOS in plasma samples was stable when stored under different stability conditions. The pharmacokinetics of LOS was found to be significantly altered when co-administered with QU: Cmax = 809.8 ± 4.1 at 40 min (tmax) to Cmax = 1124.8 ± 86.6 ng mL−1 at 120 min (tmax). This study indicates the chances of herb-drug interaction when LOS is co-administered with QU, leading to its increased bioavailability, potentiating its side effect/toxic manifestation. As QU is abundantly present in herbs and dietary food, patients of LOS therapy need to be cautious while concurrently consuming herbal preparations containing QU. This study also demonstrates the utility of HPTLC as an effective tool for pharmacokinetics study for the estimation of herb-drug interactions.

  • [1]

    S. Brantley , A. Argikar, Y.S. Lin, S. Nagar, M.F. Paine, Herb-drug interactions: challenges and opportunities for improved predictions, Drug Metab. Dispos. 42 (2014) 301317.

    • Search Google Scholar
    • Export Citation
  • [2]

    A. Fugh-Berman , E. Ernst, Herb-drug interactions: review and assessment of report reliability, Br. J. Clin. Pharmacol. 52 (2001) 587595.

    • Search Google Scholar
    • Export Citation
  • [3]

    S. Bromfield , P. Muntner, High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs, Curr. Hypertens. Rep. 15 (2013) 134136.

    • Search Google Scholar
    • Export Citation
  • [4]

    J. Daubney , P.L. Bonner, A.J. Hargreaves, J.M. Dickenson, Cardioprotective and cardiotoxic effects of quercetin and two of its in vivo metabolites on differentiated H9c2 cardiomyocytes, Basic Clin. Pharmacol. Toxicol. 116 (2015) 96109.

    • Search Google Scholar
    • Export Citation
  • [5]

    A.A. Izzo , G. Di Carlo, F. Borrelli, E. Ernst, Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction, Int. J. Cardiol. 98 (2005) 114.

    • Search Google Scholar
    • Export Citation
  • [6]

    D.A. Sica , T.W. Gehr, S. Ghosh, Clinical pharmacokinetics of losartan, Clin. Pharmacokinet. 44 (2005) 797814.

  • [7]

    S. Liu , F.L. Bu, C.M. Wei, G.Y. Yuan, B.J. Wang, R.C. Guo, Pharmacokinetics of hydrochlorothiazide, losartan and E3174 after oral doses of losartan and losartan/hydrochlorothiazide in healthy Chinese male volunteers, Pharmacol. Pharm. 3 (2012) 714.

    • Search Google Scholar
    • Export Citation
  • [8]

    M.W. Lo , M.R. Goldberg, J.B. McCrea, H. Lu, C.I. Furtek, T.D. Bjornsson, Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans, Clin. Pharmacol. Ther. 58 (1995) 641649.

    • Search Google Scholar
    • Export Citation
  • [9]

    R. Shanmugam , K. Gowthamarajan, D.L. Priyanka, K. Madhuri, V.V. Karri Narayanareddy, Bioanalytical method development and validation for herbal quercetin in nano formulation by RPU-FLC in rabbit plasm, J. Bioequiv. Availab. 5 (2013) 191196.

    • Search Google Scholar
    • Export Citation
  • [10]

    S.N. Umathe , P.V. Dixit, K.U. Bansod, M.M. Wanjari, Querce-tin pre-treatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition, Biochem. Pharmacol. 75 (2008) 16701676.

    • Search Google Scholar
    • Export Citation
  • [11]

    E.R. Lee , G.H. Kang, S.G. Cho, Effect of flavonoids on human health: old subjects but new challenges, Recent Pat. Biotechnol. 1 (2007) 139150.

    • Search Google Scholar
    • Export Citation
  • [12]

    K.J. Gohil , J.A. Patel, Herb-drug interactions: a review and study based on assessment of clinical case reports in literature, Indian J. Pharmacol. 39 (2007) 129139.

    • Search Google Scholar
    • Export Citation
  • [13]

    M.C. Morand , C. D.O. Texier, F. Regerat, C. Remesy, Bioavailability of rutin and quercetin in rats, FEBS Lett. 409 (1997) 1216.

  • [14]

    H.J. Shah , M.L. Kundlik, N.K. Patel, G. Subbaiah, D.M. Patel, B.N. Suhagia, C.N. Patel, Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS/MS, J. Sep. Sci. 20 (2009) 33883394.

    • Search Google Scholar
    • Export Citation
  • [15]

    A. Kumar , M. Debnath, J.V.L.N. Seshagiri Rao, G. Sankar, New validated stability indicating RP-HPLC bioanalytical method development and validation for simultaneous estimation of hydro-chlorothiazide, ramipril and losartan in human plasma by using PDA detector, Pharm. Anal. Acta 6 (2017) 18.

    • Search Google Scholar
    • Export Citation
  • [16]

    V.K. Karra , N.R. Pilli, J.K. Inamadugu, J.V.L.N. Seshagiri Rao, Simultaneous determination of losartan, losartan acid and amlodipine in human plasma by LC-MS/MS and its application to a human pharmacokinetic study, Pharm Methods. 3 (2012) 1825.

    • Search Google Scholar
    • Export Citation
  • [17]

    D. Goswami , A. Kumar, A.H. Khuroo, T. Monif, N.R. Thudi, V.K. Shrivastav, S.K. Dubey, A.K. Shingla, M. Prakash, S. Mehra, Pharmacokinetic estimation of losartan, losartan carboxylic acid and hydrochlorothiazide in human plasma by LC/MS/MS validated method, Clin. Res. Regul. Aff. 25 (2008) 235258.

    • Search Google Scholar
    • Export Citation
  • [18]

    M. Del Rosario Brunetto , Y. Contreras, S. Clavijo, D. Torres, Y. Delgado, F. Ovalles, C. Ayala, M. Gallignani, J.M. Estela, V.C. Martin, Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence, J. Pharm. Biomed. Anal. 50 (2009) 194199.

    • Search Google Scholar
    • Export Citation
  • [19]

    P.K. Yeung , A. Jamieson, G.J. Smith, D. Fice, P.T. Pollak, A validated RP-LC method for simultaneous determination of losartan potassium and amlodipine besilate in pharmaceutical preparations, Int. J. Pharm. 204 (2000)1722.

    • Search Google Scholar
    • Export Citation
  • [20]

    S. Shivakumar , T. Sudhir, R. Mital, G. Devala Rao, S.V.S.G.B. Prasad, LC/MS/MS method for the simultaneous estimation of losartan potassium and irbesartan in rat plasma, Int. J. Pharm. Pharm. Sci. 1 (2009) 206215.

    • Search Google Scholar
    • Export Citation
  • [21]

    S.K. Shetty , K.V. Surendranath, P. Radhakrishnanand, R.M. Borkar, P.S. Devrukhakar, J. Jogul, U.M. Tripathi, Quantitative application to a polypill by the development of stability indicating LC method for the simultaneous estimation of aspirin, atorvastatin, atenolol and losartan potassium, Am. J. Anal. Chem. 2 (2010) 5969.

    • Search Google Scholar
    • Export Citation
  • [22]

    L. González , J.A. López, R.M. Alonso, R.M. Jiménez, Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection, J. Chromatogr. A 949 (2002) 4960.

    • Search Google Scholar
    • Export Citation
  • [23]

    D.L. Hertzog , J.F. McCafferty, X. Fang, R.J. Tyrrell, R.A. Reed, In vitro evidences for simvastatin and losartan potassium interaction and its in vivo implications, J. Pharm. Biomed. Anal. 30 (2002) 74760.

    • Search Google Scholar
    • Export Citation
  • [24]

    R.A. Stearns , P.K. Chakravarty, R. Chen, S.H. Chi, Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members, Drug Metab. Dispos. 23 (1995) 207215.

    • Search Google Scholar
    • Export Citation
  • [25]

    M. Selvadurai , S.N. Meyyanathan, Sensitive and accurate estimation of losartan potassium formulation by high-performance thin-layer chromatography, Pharm. Methods 2 (2011) 9598.

    • Search Google Scholar
    • Export Citation
  • [26]

    A.K Kolsure , B.B. Chavan, A.R. Chabukswar, B.S. Kuchekar, Development and validation of a HPTLC method for simultaneous estimation of atorvastatin calcium and losartan potassium in combined dosage form, Asian J. Biomed. Pharm. 4 (2014) 2024.

    • Search Google Scholar
    • Export Citation
  • [27]

    R. Dubey , V.K. Bhusari, S.R. Dhaneshwar, Validated HPTLC method for simultaneous estimation of losartan potassium and metolazone in bulk drug and formulation, Pharm. Lett. 3 (2015) 334342.

    • Search Google Scholar
    • Export Citation
  • [28]

    K.B Bodiwala , K. Mali, P. Patel, P.B. Prajapati, B.P. Marolia, G.G. Kalyankar, Estimation of losartan potassium and ramipril in their combined dosage form by validated HPTLC method, Eurasian J. Anal. Chem. 12 (2017) 167177.

    • Search Google Scholar
    • Export Citation
  • [29]

    K.E. McCarthy , Q. Wang, E.W Tsai, R.E. Gilbert, D.P. Ip, M.A. Brooks, Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography, J. Pharm. Biomed. Anal. 17 (1998) 671677.

    • Search Google Scholar
    • Export Citation
  • [30]

    S.V. Shah , I.S. Rathod, B. Suhagai, S.S. Savale, Simultaneous determination of losartan and hydrochlorothiazide in combined dosage forms by first-derivative spectroscopy and high-performance thin-layer chromatography, J. AOAC Int. 84 (2001) 17151723.

    • Search Google Scholar
    • Export Citation
  • [31]

    L.K. Santhana , S. Lakshmi, Simultaneous analysis of losartan potassium, amlodipine besylate, and hydrochlorothiazide in bulk and in tablets by high-performance thin-layer chromatography with UV-absorption densitometry, J. Anal. Methods Chem. 2012 (2012) 108281. Doi: 10.1155/2012/108281.

    • Search Google Scholar
    • Export Citation
  • [32]

    D. Tsvetkova , D. Obreshkova, Application of validated TLC-densitometric method for simultaneous identification and determination of losartan potassium, telmisartan, and valsartan in tablets, J. Planar Chromatogr. 25 (2012) 326330.

    • Search Google Scholar
    • Export Citation
  • [33]

    Guidance for Industry. Bioanalytical Method Validation, Centre for Drug Evaluation and Research (CDER), US Department of Health and Human Services, Food and Drug Administration, Rockville, MD, 2018.

    • Search Google Scholar
    • Export Citation
  • [34]

    D.A Sica , T.W. Gehr, S. Ghosh, Clinical pharmacokinetics of losartan, Clin. Pharmacokinet. 44 (2005) 797814.

For Submission Guideline click HERE

Manuscript Submission: JPC Manuscript Submission

Senior editors

Editor(s)-in-Chief: B. Spangenberg

Managing Editor: Kakuk Ágnes

Editorial Board

  • T.H. Dzido (Lublin, Poland)
  • Á. M. Móricz (Budapest, Hungary)
  • C.F. Poole (Detroit, MI, USA)
  • E. Reich (Muttenz, Switzerland)
  • B. Renger (Radolfzell, Germany)
  • I. Vovk (Ljubljana, Slovenia)

 

Advisory Board

  • E. BODOKI (Cluj-Napoca, Romania)
  • U. A. TH. BRINKMAN (Amsterdam, The Netherlands)
  • I. CHOMA (Lublin, Poland)
  • V. COMAN (Cluj-Napoca, Romania)
  • W. DAMMERTZ (Kressbronn, Germany)
  • K. FERENCZI-FODOR (Budapest, Hungary)
  • G. INDRAYANTO (Surabaya, Indonesia)
  • R. E. KAISER (Bad Dürkheim, Germany)
  • I. KLEBOVICH (Budapest, Hungary)
  • T. KOWALSKA (Katowice, Poland)
  • L. LEPRI (Florence, Italy)
  • E. MINCSOVICS (Budapest, Hungary)
  • D. NUROK (Indianapolis, IN, USA)
  • B. RENGER (Radolfzell, Germany)
  • J. K. RÓŻYŁO (Lublin, Poland)
  • J. SHERMA (Easton, PA, USA)
  • M. WAKSMUNDZKA-HAJNOS (Lublin, Poland)
  • D. WEDGE (Mississippi, USA)

A. Kakuk - Managing Editor, Akadémiai Kiadó
Address: P.O. Box 245. H-1519 Budapest, Hungary
Fax: +36 1 464 82 95
E-mail: jpc@akkrt.hu

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences

 

Journal of Planar Chromatography - Modern TLC
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
6
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0933-4173 (Print)
ISSN 1789-0993 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 10 0 0
May 2021 9 0 0
Jun 2021 10 0 0
Jul 2021 2 0 0
Aug 2021 12 0 0
Sep 2021 13 0 0
Oct 2021 0 0 0